|

MnSOD Mimetic BMX-001 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: BMX-001, Manganese (III) ortho N-Butoxyethylpyridylporphyrin, Manganese Butoxyethyl Pyridyl Porphyrin, Mitochondrial Manganese Superoxide Dismutatse Mimetic BMX-001, Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin +1 more

Pipeline

Phase 2: 1

Top Sponsors

  • NRG Oncology1

Indications

  • Stomatitis1
  • Stage IVB Lip and Oral Cavity Cancer AJCC v81
  • Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v81
  • Stage II Hypopharyngeal Carcinoma AJCC v81
  • Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v81

Gilbert, Arizona1 trial

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Arizona Center for Cancer Care - Gilbert

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.